These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31315936)

  • 21. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of adverse pregnancy events and cardiovascular disease in women 50 years of age and older.
    Freibert SM; Mannino DM; Bush H; Crofford LJ
    J Womens Health (Larchmt); 2011 Feb; 20(2):287-93. PubMed ID: 21265636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Disease in Women.
    Kurrelmeyer K
    Methodist Debakey Cardiovasc J; 2017; 13(4):183-184. PubMed ID: 29744009
    [No Abstract]   [Full Text] [Related]  

  • 24. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of cardiovascular disease in women: the obstetric-gynecologist's point of view.
    Perrone G; Brunelli R
    Ther Apher Dial; 2013 Apr; 17(2):162-8. PubMed ID: 23551672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating cardiovascular disease in women.
    Taggu W; Lloyd G
    Menopause Int; 2007 Dec; 13(4):159-64. PubMed ID: 18088527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients?
    Seely EW; Tsigas E; Rich-Edwards JW
    Semin Perinatol; 2015 Jun; 39(4):276-83. PubMed ID: 26117165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome.
    Armeni E; Lambrinoudaki I
    Curr Vasc Pharmacol; 2019; 17(6):579-590. PubMed ID: 30156159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women.
    Rajendran A; Minhas AS; Kazzi B; Varma B; Choi E; Thakkar A; Michos ED
    Atherosclerosis; 2023 Nov; 384():117269. PubMed ID: 37752027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
    Marchesan LB; Spritzer PM
    Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing Cardiovascular Risk Across the Arc of a Woman's Life: Sex-Specific Prevention and Treatment.
    Verghese D; Muller L; Velamakanni S
    Curr Cardiol Rep; 2023 Sep; 25(9):1053-1064. PubMed ID: 37498450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities in women's cardiovascular health.
    McSweeney JC; Pettey CM; Souder E; Rhoads S
    J Obstet Gynecol Neonatal Nurs; 2011; 40(3):362-71. PubMed ID: 21477222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
    Ofori S; Dodiyi-Manuel S; Akpa MR
    J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular health and ovarian aging.
    Quinn MM; Cedars MI
    Fertil Steril; 2018 Oct; 110(5):790-793. PubMed ID: 30316413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention.
    Elder P; Sharma G; Gulati M; Michos ED
    Am J Prev Cardiol; 2020 Jun; 2():100028. PubMed ID: 34327455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Risk Factors: Does Sex Matter?
    Wells GL
    Curr Vasc Pharmacol; 2016; 14(5):452-457. PubMed ID: 27456107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on sex specific risk factors in cardiovascular disease.
    Nguyen AH; Hurwitz M; Sullivan SA; Saad A; Kennedy JLW; Sharma G
    Front Cardiovasc Med; 2024; 11():1352675. PubMed ID: 38380176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).
    Wassertheil-Smoller S; Shumaker S; Ockene J; Talavera GA; Greenland P; Cochrane B; Robbins J; Aragaki A; Dunbar-Jacob J
    Arch Intern Med; 2004 Feb; 164(3):289-98. PubMed ID: 14769624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone therapy in menopause: An update on cardiovascular disease considerations.
    Hale GE; Shufelt CL
    Trends Cardiovasc Med; 2015 Aug; 25(6):540-9. PubMed ID: 26270318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.